Evaluation of hepatitis C virus kits.

AUTOR(ES)

Chaudhary, R K

RESUMO

Hepatitis C virus (HCV) antibodies were detected in 85.9% of the samples by commercial enzyme immunoassay (EIA) kits. Most EIA-positive samples were reactive (80%) by the RIBA HCV test (Ortho Diagnostics). Samples with optical density values greater than or equal to 2.0 were mostly reactive (87%) by RIBA HCV test, in contrast to those with values less than or equal to 1.0 (6.6%). Samples which were indeterminate by the RIBA HCV test were positive (88.4%) by HCV neutralization EIA (Abbott Laboratories), along with 29.4% of samples which were nonreactive by the RIBA HCV test.

Documentos Relacionados

• Comparative evaluation of commercial rubella virus antibody kits.
• Comparative evaluation of commercial fluorescent treponemal antibody-absorbed test kits.
• Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.
• T-cell detection with monoclonal antibody T101 kits.
• The need for primary quality control of commercially available immunoassay kits.